147

therapeutic
published patents

56

oncology
published patents

310

research tools

46

diagnostic
published patents

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

Applications
Therapy areas
Download
More posts

Establishment of redifferentiated cells after treatment of neoplastic

When undifferentiated, invasive neoplastic cell lines are treated with an optimal time / concentration combination of curcumin (under conditions […]

A breast-cancer cell line expressing a bret biosensor to monitor pi-3

We have developed a MCF7-derived cell line stably co-expressing the pleckstrin homology (PH) domain of Akt fused to Renilla luciferase (Luc-Akt-PH) […]

Lgi1-null mouse: a model for epilepsy

LGI1 (leucine-rich, glioma-inactivated 1) mutations are responsible for an inherited focal epileptic syndrome with onset in adolescence. LGI1-related […]

Rat anti-mouse cd26 (mouse dipeptidyl peptidase iv, dpp iv) (clone

Rat monoclonal antibody recognizing the cell surface antigen DPP IV (CD26) involved in T cell activation and in the processing of a variety of […]

Rat anti-mouse cd24 (mouse, p31) (clones h193-4 ; h194-563)

Rat monoclonal antibody recognizing a glycosyl-phosphatidylinositol-anchored glycoconjugate of 28-33 kDa (P31) expressed in developing mouse brain. […]

Rat anti-mouse cd8 beta subunit (mouse cd8beta) (clone h37-17.2)

Thymus-derived CD8+ TCRab+ T cells typically express heterodimericCD8ab consisting of a disulfide-linked a and b chain. CD8 can also be expressed as […]

Rat mesothelial cell line f1-1

Transformed rat mesothelial cell line isolated from the peritoneal fluid of a female rat (Fischer F344) after 292 days of induction with crocidolite […]

More posts

You might also be interested in